期刊文献+

STAT3信号转导通路调控人宫颈癌Hela细胞增殖、凋亡的机制 被引量:5

Mechanism of STAT3 signal transduction pathway in regulation of proliferation and apoptosis of human cervical cancer Hela cells
原文传递
导出
摘要 目的:探讨信号传导和转录激活因子3(Stat3)通路与人宫颈癌Hela细胞增殖、凋亡的关系,明确以Stat3为靶向的信号传导通路调控Hela细胞增殖、凋亡的分子机制。方法:人宫颈癌Hela细胞用酪氨酸激酶(JAK)抑制剂AG490处理,采用噻唑蓝(MTT)比色法检测细胞增殖;流式细胞仪(FCM)测细胞凋亡及细胞周期;蛋白免疫印迹法(Western blot)检测JAK2、Stat3、磷酸化Stat3(p-Stat3)、CyclinD1、Survivin的表达。结果:人宫颈癌Hela细胞中Stat3、p-Stat3、JAK2呈阳性表达。AG490呈时间和剂量依赖的方式抑制Hela细胞的增殖,促进其凋亡(P<0.05)。Western blot检测显示p-Stat3、CyclinD1、Survivin的表达水平随作用剂量的增大而逐渐下降(P<0.05),Stat3的表达未见明显变化(P≥0.05)。结论:Stat3信号转导通路与宫颈癌Hela细胞的增殖、凋亡密切相关,可能通过其下游靶基因蛋白CyclinD1、Survivin发挥作用。阻断Stat3信号通路可能为宫颈癌的防治提供一种新的策略。 Objective : To explore the relationship between signal transducer and activator of transcription 3 ( STAT3 ) pathway and proliferation and apoptosis of human cervical cancer Hela cells, analyze the molecular mechanism of STAT3 signal transduction pathway in regulation of proliferation and apoptosis of human cervical cancer Hela cells. Methods: Human cervical cancer Hela cells were treated with AG490 (a tyrosine kinase inhibitor) , MTT assay was used to detect cell proliferation; flow eytometry was used to detect apoptosis and cell cycle; Western blot was used to detect the expressions of tyrosine kinase 2, STAT3, phosphorylated STAT3, CyelinD1 and Survivin. Results: STAT3, phosphorylated STAT3 and tyrosine kinase 2 expressed in human cervical cancer Hela ceils. AG490 inhibited the proliferation and promoted the apoptosis of Hela cells by a time and dose dependent manner ( P 〈 0. 05 ) . Western blot detection showed that the expression levels of phosphorylated STAT3, CyelinD1 and Survivin decreased gradually with the increase of dose (P 〈 O. 05 ) , the expression of STAT3 didnl change (P≥0.05 ) . Conclusion: STAT3 signal transduction pathway is related to proliferation and apoptosis of human cervical cancer Hela cells closely, which may play a role through downstream target gene proteins (CyclinD1 and Survivin ) . Blocking STAT3 signal transduction pathway may become a new strategy to prevent and treat cervical cancer.
出处 《中国妇幼保健》 CAS 北大核心 2011年第29期4591-4594,共4页 Maternal and Child Health Care of China
关键词 宫颈癌 信号传导与转录激活因子3 增殖 凋亡 Cervical cancer Signal transducer and activator of transcription 3 Proliferation Apoptosis
  • 相关文献

参考文献2

二级参考文献9

  • 1Wang S,J Gastrointest Surg,1999年,3卷,200页
  • 2Spiekemaann K, Biethahn S, Wilde S, et al. Constitutive activation of STAT transcription factors in acute myelogenous leukemia[ J]. Eur J Hae matol,2001,67(2) :63-71.
  • 3Mizoguchi M, Betensky RA, Batchelor TT, et al. Activation of STA33, MAPK ,and AKT in malignant astrocytic gliomas: correlation with EGFR status ,tumor grade,and survival[ J ]. J Neuropathol Exp Neurol,2006,65( 11 ) :1181-1188.
  • 4Sulkowska M, Golaszewska J,Wincewicz A, et al. Leptin From Regulation of fat Metabolism to Stimulation of Breast Cancer Growth[ J]. Pathol Oncol Res,2006,12( 11 ) :69-72.
  • 5Ni Z, Lou W, Lee SO, et al. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma[J]. J Urol,2002,167(4):1859-1862.
  • 6Rahaman SO, Harbor PC, Chernova O, et al. Inhibition of constitutively active STAT3 suppresses proliferation and induces apoptosis in glioblastoma multiform cells [ J ]. Oncogene, 2002,21 ( 55 ) : 8404- 8413.
  • 7Toyonaga T, Nakanl K, Nagano M, et al. Blockade of constitutively activated janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer [ J ]. Cancer Lett ,2003,201 ( ! ) : 107-116.
  • 8Kusaba T, Nakayama T,Yamazumi K, et al. Expression of p-STA33 in human colorectal adenocarcinoma and adenoma correlation with clinicopathological factors [ J ]. J Clin Pathol, 2005,58 ( 8 ) : 833- 838.
  • 9冯凯,吕晓霞,许伟华.P^(16)和CyclinD_1在不同胃病患者胃粘膜中表达的临床意义[J].山东医药,2002,42(3):9-11. 被引量:2

共引文献35

同被引文献39

  • 1杨华静,吴晓梅,万小平.STAT3在妇科肿瘤中的研究进展[J].肿瘤,2010,30(11):985-988. 被引量:4
  • 2马瑞波,杨大刚,孙诚谊,王众.Chk2在原发性肝癌和肝非肿瘤组织中的表达[J].贵州医药,2012,36(3):219-221. 被引量:1
  • 3黄晓园,高庆蕾,庄亮,曹阳,马全富,周剑峰,马丁.Chk1/2和Plk1蛋白在宫颈良恶性病变组织中的表达及其意义[J].中国癌症杂志,2007,17(6):429-432. 被引量:12
  • 4王玉祥,祝淑钗.细胞周期检测点激酶CHK1、CHK2与放射敏感性[J].肿瘤学杂志,2007,13(3):178-181. 被引量:5
  • 5Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, etal. Cervical Cancer Prevention in Low- and Middle-Income Countries= Feasible, Affordable, Essential[J].Cancer Prev Res,2012,5(1): 11-17.
  • 6Arbyn M, Castellsagud X, de Sanjosd S, et al. Worldwide burden of cervical cancer in 2008[J]. Ann Oncol, 2011,22(12): 2675- 2686.
  • 7Wang Q, Zhang C, Walayat S, et al. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population[J].Eur J Obstet Gynecol Reprod Biol,2011,158(2):330- 333.
  • 8Yang SF, Yuan SS, Yeh YT, et al. Positive association between STAT3 and Ki-67 in cervical intraepithelial neoplasia [J]. Kaohsiung J Med Sci,2006,22 (11):539-546.
  • 9Huang HH, Zhao WR, Yang D. Stab induces oncogenic Skp2 expression in human cervical carcinoma cells[J].Biochem Biophys Res Cormnun,2012,418(1): 186-190.
  • 10Sahasrabuddhe VV,Parham GP,Mwanahamuntu MH. Cervical Cancer Prevention in Low and Middle-Income Countries:Feasible,Aff ordable,Essential[J].Cancer Prev Res,2012,(01):11.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部